MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (L36155) Retirement - Effective October 11, 2026

Date Posted: August 27, 2026

This Local Coverage Determination (LCD) has been retired under contractor numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Medicare Coverage Database (MCD) Number: L36155

Effective Date: October 11, 2026

Rationale:

This LCD is being superseded by MolDX: Genetic Testing for Hereditary Thrombophilia (L40242)

Visit the Retired LCDs webpage to access the retired LCDs.

Last Updated Aug 27 , 2026